Pharmacokinetics of the Yougui Pill in Experimental Autoimmune Encephalomyelitis Model Rats and Its Pharmacological Activity in Vitro

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s203874
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Tanshinone IIA Attenuates Experimental Autoimmune Encephalomyelitis in Rats

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Mechanical Hypernociception in Experimental Autoimmune Encephalomyelitis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2009English

Therapeutic Potential of Agmatine in the Experimental Autoimmune Encephalomyelitis

Vojnosanitetski Pregled
MedicinePharmacology
2019English

PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model

Frontiers in Pharmacology
Pharmacology
2017English

Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

PLoS ONE
Multidisciplinary
2016English

Immunohistochemical Analysis of Spinal Cord Components in Mouse Model of Experimental Autoimmune Encephalomyelitis

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2018English

K+ Channel Alterations in the Progression of Experimental Autoimmune Encephalomyelitis

Neurobiology of Disease
Neurology
2012English

Reduced Proteasomal Activity Contributes to the Accumulation of Carbonylated Proteins in Chronic Experimental Autoimmune Encephalomyelitis

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy